//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at http://tctmd.com
TCTMD









Loading...
The first comprehensive guideline for cardiovascular-kidney-metabolic (CKM) syndrome has been released by the @ahascience.bsky.social and @accintouch.bsky.social to outline the prevention, detection, evaluation, and management of CKM. www.tctmd.com/news/ahaacc-...
#NYValves2026 is next week, but there’s still time to secure your spot and unite with your colleagues at the global structural heart summit.🗽⏰ Don’t let a busy schedule hold you back! Choose your ✨ perfect day ✨ and get more for less with One-Day Access! 📅 🔗 https://ow.ly/jubj50Zc55T
CMS Proposes Expanding TAVI Coverage to Asymptomatic Patients
Vitamin K Supplementation May Reduce Coronary Calcification: VitaK-CAC
New 10-Year TAVI Data Generally ‘Reassuring’ But Highlight Challenges
Now Published: PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States
Data from the TRISCEND II trial suggest that hospital cost and length of stay for patients undergoing TTVR vary by complication, with new pacemaker or cardiac implantable electronic device (CIED) implantation and renal replacement therapy as the primary drivers. www.tctmd.com/news/triscen...
A new joint consensus document by @scct-heart.bsky.social and @scainews.bsky.social offers guidance on using and reporting CT-FFR, with the hope that it will improve adoption, increase consistency, and boost outcomes for patients undergoing coronary CT angiography. www.tctmd.com/news/scct-sc...
In Europe, one in 25 patients undergoing TAVI for severe aortic stenosis has died between 30 days and 12 months after the procedure, with most deaths being noncardiovascular, according to new data from the TRITAVI registry. www.tctmd.com/news/followi...
For PCI patients, prasugrel stands out as the best oral P2Y12 inhibitor, associated with a lower likelihood of MACE, MI, and stent thrombosis without an increase in major bleeding, based on a new meta-analysis. www.tctmd.com/news/meta-an...
5m
1d
43m
18h
21h
23h
3d
1d
2d
4d
TCTMD
TCTMD
CMS Proposes Expanding TAVI Coverage to Asymptomatic Patients
CMS Proposes Expanding TAVI Coverage to Asymptomatic Patients [email protected] Wed, 06/17/2026 - 10:29 L.A. McKeown The proposed decision memo also paves the way for triaging by chart review and enhancing flexibility for heart team decisions.
www.tctmd.com
TCTMD
TCTMD
Cardiovascular Research Foundation
TCTMD
TCTMD
TCTMD
The condition is a main determinant of CV risk and a major contributor to premature mortality, Chiadi Ndumele says.
www.tctmd.com
AHA/ACC Release First Comprehensive Guideline on CKM Syndrome
TCTMD
The expert consensus document was written to improve adoption, increase consistency, and boost outcomes.
www.tctmd.com
Vitamin K Supplementation May Reduce Coronary Calcification: VitaK-CAC [email protected] Tue, 06/16/2026 - 16:47 Yael L. Maxwell But some argue that without knowledge of what the changes in CAC mean, these supplements are not ready for routine use.
www.tctmd.com
SCCT, SCAI Offer Guidance on Using and Reporting CT-FFR
Vitamin K Supplementation May Reduce Coronary Calcification: VitaK-CAC
TCTMD
Video
Compared with clopidogrel, the drug comes with better efficacy and less risk of major bleeding than ticagrelor.
www.tctmd.com
The data should help with conversations around patient selection and futility, researchers say.
www.tctmd.com
| tctmd.com
Following Successful TAVI, 4% Die between 1 and 12 months: TRITAVI
Now Published: PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States [email protected] Tue, 06/16/2026 - 11:43 Caitlin E. Cox Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.
www.tctmd.com
Now Published: PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States
New pacemaker/CIED implants and need for renal replacement therapy were the biggest contributors.
www.tctmd.com
New 10-Year TAVI Data Generally ‘Reassuring’ But Highlight Challenges [email protected] Tue, 06/16/2026 - 13:17 Todd Neale High mortality in elderly patients followed over a decade might complicate the lessons learned compared with SAVR.
www.tctmd.com
| tctmd.com
New 10-Year TAVI Data Generally ‘Reassuring’ But Highlight Challenges